Fotis Polydoros

Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis

Ilias P. Gomatos, Christopher Halloran, Paula Ghaneh et al. · Annals of Surgery · 2015 · 125 citations

Medicine, Surgery, Gastroenterology +15

Asciminib, a First-in-Class STAMP Inhibitor, Provides Durable Molecular Response in Patients (pts) with Chronic Myeloid Leukemia (CML) Harboring the T315I Mutation: Primary Efficacy and Safety Results from a Phase 1 Trial

Jörge E. Cortes, Timothy P. Hughes, Michael J. Mauro et al. · Blood · 2020 · 53 citations

Medicine, Oncology, Pharmacology +9

Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results

Jörge E. Cortes, Koji Sasaki, Dong‐Wook Kim et al. · Leukemia · 2024 · 51 citations · Full text

Medicine, Oncology, Pharmacology +9

Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results

Michael J. Mauro, Timothy P. Hughes, Dong‐Wook Kim et al. · Leukemia · 2023 · 47 citations · Full text

Medicine, Oncology, Pharmacology +10

Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients

Claire Lucas, Robert J. Harris, Alison Holcroft et al. · Leukemia · 2015 · 39 citations · Full text

Medicine, Oncology, Pharmacology +12